Molina Healthcare (NYSE:MOH) Issues FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 24.500- for the period, compared to the consensus EPS estimate of 26.070. The company issued revenue guidance of -.

Molina Healthcare Stock Up 0.6 %

NYSE:MOH traded up $2.04 during mid-day trading on Wednesday, hitting $317.45. The stock had a trading volume of 806,764 shares, compared to its average volume of 577,415. The stock has a 50-day simple moving average of $298.36 and a two-hundred day simple moving average of $318.39. The company has a market capitalization of $18.16 billion, a PE ratio of 16.12, a PEG ratio of 0.96 and a beta of 0.54. Molina Healthcare has a twelve month low of $272.69 and a twelve month high of $423.92. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. On average, equities research analysts anticipate that Molina Healthcare will post 23.44 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on MOH. Wells Fargo & Company raised their target price on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Monday, November 4th. Cantor Fitzgerald restated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, October 24th. Truist Financial lowered their price objective on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded shares of Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 31st. Finally, Robert W. Baird lowered their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Molina Healthcare has an average rating of “Moderate Buy” and an average target price of $359.18.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.